SCHEMBL13853971

SCHEMBL13853971

CCOP(=O)(CCCCNC(=O)OCc1ccccc1)OCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.58
▸ TGM2 P21980 1/20 0.55
▸ LMNA P02545 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ KEAP1 Q14145 3/20 0.53
▸ NFE2L2 Q16236 3/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ MAPT P10636 1/20 0.50
▸ HDAC3 O15379 1/20 0.48
▸ HDAC4 P56524 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC7 Q8WUI4 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HDAC10 Q969S8 1/20 0.48
▸ HDAC11 Q96DB2 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.48
▸ HDAC9 Q9UKV0 1/20 0.48
▸ HDAC5 Q9UQL6 1/20 0.48
▸ NCOR2 Q9Y618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13854151 0.94 HTT (0.54) HTTTGM2LMNASMN1; SMN2KEAP1
SCHEMBL1439677 0.91 LMNA (0.57) HTTTGM2LMNASMN1; SMN2KEAP1
SCHEMBL9202853 0.90 HTT (0.55) HTTTGM2LMNASMN1; SMN2KEAP1
SCHEMBL9204222 0.88 LMNA (0.53) HTTTGM2LMNASMN1; SMN2KEAP1
SCHEMBL13725441 0.86 HTT (0.59) HTTTGM2LMNASMN1; SMN2KEAP1
SCHEMBL13725748 0.84 LMNA (0.51) HTTTGM2LMNASMN1; SMN2L3MBTL1
SCHEMBL13725051 0.84 LMNA (0.51) HTTTGM2LMNASMN1; SMN2L3MBTL1
SCHEMBL7282990 0.84 HSD17B10 (0.56) HTTLMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL24486765 0.83 HTT (0.65) HTTTGM2LMNASMN1; SMN2KEAP1
SCHEMBL18254066 0.82 HTT (0.81) HTTTGM2LMNASMN1; SMN2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090123507-A1 Metal Oxide Nanoparticles Coated With Specific N-Acylaminomethylene Phosphonates CIBA SPECIALTY CHEMICALS CORP. 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090123507-A1 Metal Oxide Nanoparticles Coated With Specific N-Acylaminomethylene Phosphonates PHOSPHO1, ACP1, PNN HTT 2508/4885TGM2 2740/4885LMNA 3551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback